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Abstract
Schizophrenia is a debilitating neuropsychiatric disorder that affects 1% of the US population. 
Based on twin and genome-wide association studies, it is clear that both genetics and 
environmental factors increase the risk for developing schizophrenia. Moreover, there is evidence 
that conditions in utero, either alone or in concert with genetic factors, may alter 
neurodevelopment and lead to an increased risk for schizophrenia. There has been progress in 
identifying genetic loci and environmental exposures that increase risk, but there are still 
considerable gaps in our knowledge. Furthermore, very little is known about the specific 
neurodevelopmental mechanisms upon which genetics and the environment act to increase 
disposition to developing schizophrenia in adulthood. Vitamin D deficiency during the perinatal 
period has been hypothesized to increase risk for schizophrenia in humans. The developmental 
vitamin D (DVD) deficiency hypothesis of schizophrenia arises from the observation that disease 
risk is increased in individuals who are born in winter or spring, live further from the equator or 
live in urban vs. rural settings. These environments result in less exposure to sunlight, thereby 
reducing the initial steps in the production of vitamin D. Rodent models have been developed to 
characterize the behavioral and developmental effects of DVD deficiency. This review focuses on 
these animal models and discusses the current knowledge of the role of DVD deficiency in 
altering behavior and neurobiology relevant to schizophrenia.
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The prevalence of mental illness is over 18% among adults in the USA (Substance Use and 
Mental Health Services Administration, 2014). Mental illness contributes significantly to 
premature death, lost productivity and healthcare costs to the affected individual and society 
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as a whole. Although significant advances have been made in understanding the etiology of 
mental illness, there is still a great deal that is unknown about the specific factors that 
increase risk for these devastating diseases. Genetics has been shown to have a significant 
role in susceptibility for psychiatric disorders and genome-wide association and sparse 
sequencing studies have begun to identify risk loci that harbor polymorphisms and 
functional pathways for further study (Cross-Disorder Group of the Psychiatric Genomics 
Consortium 2013; Network & Pathway Analysis Subgroup of Psychiatric Genomics 
Consortium 2015; Ripke et al. 2013; Sullivan 2015). However, heritability estimates from 
twin studies (Kendler 2001) and more recent genome-wide single nucleotide polymorphism 
(SNP) analysis (Cross-Disorder Group of the Psychiatric Genomics Consortium et al. 2013) 
indicates that environmental factors and gene by environment interactions are also likely to 
contribute significantly to increased risk. As increased risk for psychiatric diseases is 
thought to depend, in part, on neurodevelopmental changes that occur early in life, the role 
of early environment including early life stressors, perinatal immune activation and dietary 
deficiencies have been examined as potential environmental factors. There are many 
excellent reviews on the role of perinatal and postnatal stress, maternal immune activation 
and in utero protein deficiency on disease status in adulthood (Babenko et al. 2015; Brown 
2011; Knuesel et al. 2014; Tarantino et al. 2012). In this review, we will focus on the 
literature describing the role of vitamin D deficiency and increased risk for schizophrenia 
with a focus on animal models.
A slight but significant increased risk for schizophrenia has been observed in individuals 
born in winter or spring in human epidemiological studies (McGrath 2007; Torrey et al. 
1997) and this effect increases with distance from the equator (Davies et al. 2003). 
Moreover, the offspring of individuals who migrate from more equatorial regions to colder 
climates are also at increased risk for schizophrenia (Cantor-Graae & Selten 2005), as are 
the offspring of city-dwellers in comparison to those who live in rural regions (March et al. 
2008). There are many factors that vary across these groups including socioeconomic status, 
nutritional intake and exposure to pathogens, but one factor, exposure to sunlight and its 
effect on levels of the active form of vitamin D, 1,25-dihydroxyvitamin D3 (hereafter 
referred to as vitamin D), has emerged as a focus of research. The first chemical reaction in 
the formation of vitamin D is driven by exposure of the skin to sunlight (Berridge 2015) and 
vitamin D levels are closely tied to sun exposure (Webb & Holick 1988) leading to the 
hypothesis that vitamin D levels are a mediating factor that increases risk for schizophrenia 
as well as a host of other health problems (McGrath 2001). Reports of vitamin D deficiency 
as a world pandemic (Holick 2008) have brought this topic into focus and accelerated the 
pace of research in this area.
The health benefits of exposure to sunlight were first appreciated in the last century when it 
was shown that exposure to the sun was curative for rickets (Hess & Unger 1921). 
Subsequent studies identified vitamin D as the antirachitic factor (Holick et al. 1982). Since 
then, our understanding of the function of vitamin D has expanded beyond its role in 
calcium and phosphate homeostasis, bone formation and maintenance. More recently, 
vitamin D has been described as a neuroactive steroid hormone involved in brain 
development and function (Garcion et al. 2002).
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Vitamin D exerts its effects by binding to the vitamin D receptor (VDR), a member of the 
nuclear hormone receptor family, at vitamin D response elements (VDREs) within the 
promoter regions of vitamin D-responsive genes. Once activated, the VDR regulates gene 
expression and stimulates intracellular signaling pathways (Ryan et al. 2015). The VDR is 
ubiquitously expressed in a wide range of tissues including rodent and human brain (Burkert 
et al. 2003; Cui et al. 2007; Eyles et al. 2005) and there are thousands of VDRE in the 
genome (Carlberg 2014) supporting the numerous and pleiotropic effects that have been 
attributed to vitamin D.
The VDR is expressed in dopaminergic neurons in both human and rat substantia nigra, 
hippocampus and prefrontal cortex (Cui et al. 2013; Eyles et al. 2005) – regions implicated 
in schizophrenia. Expression in the substantia nigra in rats emerges early in development 
and increases until weaning (Cui et al. 2013). This finding along with the evidence for 
delayed dopamine (DA) cell differentiation (Kesby et al. 2013) and DA-mediated behavioral 
deficits in rodents exposed to developmental vitamin D (DVD) deficiency (Eyles et al. 
2013) have led to the hypothesis that exposure to vitamin D deficiency could influence the 
development of dopaminergic neurons and have serious implications for the development of 
neuropsychiatric disease.
Although human epidemiological studies present compelling evidence for elevated risk for 
schizophrenia based on vitamin D production, the existence of numerous and often 
immeasurable environmental factors and the inherent ethical and logistical challenges of 
conducting developmental research in humans have led to the development of rodent models 
of DVD deficiency. These animal models are being used to elucidate the role of vitamin D 
during development on dopaminergic circuitry and behaviors with the ultimate goal of 
developing interventions that could alter the onset, severity or course of schizophrenia and 
other neuropsychiatric diseases.
An animal model of DVD deficiency
There are obvious hurdles that impede human studies of nutritional deficiencies during 
development and their effect on behavior later in life. For example, the inability to control 
for numerous and life-long environmental challenges that an individual encounters and that 
have the potential to affect the development of a psychiatric disease makes it difficult to 
specifically study the effects of perinatal exposure to a nutritional deficiency. Furthermore, 
longitudinal studies that span the perinatal period through adulthood, when most psychiatric 
diseases have their onset, are labor-intensive and logistically challenging. In addition to, and 
more relevant than these, logistical hurdles are the obvious ethical problems with 
manipulating nutritional intake during gestation and critical developmental periods. 
Moreover, the inability to access brain tissue in humans to evaluate underlying mechanistic 
changes presents an insurmountable challenge, although advances in neuroimaging have 
provided relevant insights. In order to circumvent these logistical and ethical hurdles, 
research has turned to the use of rodent models to study the effect of exposure to nutritional 
deficiencies during the perinatal period on brain development and neurobehavioral outcomes 
in adulthood.
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Rodents are good models for these investigations for several key reasons. First, they have a 
relatively short gestation period and lifespan, making it more feasible to measure the effect 
of a perturbation during development into adulthood (around 60–80 days). Additionally, 
rodent models allow for control over the environment, making it possible to manipulate a 
single variable during a specific window of time while controlling for other variables as 
much as possible. Moreover, rodents have comparable neurobiological and physiological 
systems to humans – a feature that ultimately makes studies in rodents. Furthermore, rodent 
models have been used extensively to study behavior and specific assays have been 
developed to model certain aspects of schizophrenia (Table 1). Finally, there are advanced 
molecular and genomic tools available for rodents that enable assessment of underlying 
mechanisms (i.e. dysregulation of specific genes, changes in neurotransmitter systems and 
brain morphological differences). These reasons make rodent models ideal to study the 
effects of vitamin D deficiencies during developmental on neurobehavioral outcomes in 
adult offspring.
DVD deficiency: effects on behavior
Subsequent to the hypothesis regarding the role of DVD deficiency as a candidate risk factor 
for schizophrenia (McGrath 1999), McGrath and colleagues developed a rodent model of 
DVD deficiency to test its effects on brain development and behavior in adulthood. The 
DVD deficiency model exposes rodent dams to a diet completely deficient in vitamin D for 
6 weeks prior to conception and through gestation until birth. After pups are born, the 
mother is switched back to a diet containing normal levels of vitamin D. The effects of DVD 
deficiency have been assessed primarily in adult offspring of outbred Sprague-Dawley rats, 
or in a few cases, inbred mouse strains. As DVD deficiency has primarily been associated 
with increased risk for schizophrenia, the behavioral assays used have focused on specific 
aspects of the positive (e.g. hallucinations and delusions), negative (e.g. anti-social and lack 
of motivation) and cognitive deficits that can be modeled in rodents. Specific 
endophenotypes of schizophrenia, traits that are enriched in individuals with the disease but 
are not necessarily symptoms, can also be assessed in rodent models. Table 2 summarizes 
behavioral studies assessing the effects of DVD deficiency.
Cognitive deficits
Cognitive deficits are among the core symptoms observed in schizophrenic patients, are 
strongly correlated with functional outcomes and are not well managed by current therapies 
(Green 1996; Green et al. 2004; Vingerhoets et al. 2013) making the need for more effective 
treatments imperative. The National Institute of Mental Health supported the Measurement 
and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative 
aimed at fostering a better understanding of the mechanisms underlying cognitive deficits in 
schizophrenia. The MATRICS identified seven domains: attention/vigilance, working 
memory, reasoning and problem solving, processing speed, visual learning and memory, 
verbal learning and memory and social cognition (Young et al. 2009b). Rodent models for 
most of these domains have been developed (Table 1) and appear to show good construct 
validity (Arguello & Gogos 2010; Kellendonk et al. 2009). Cognitive studies in rodents 
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exposed to DVD deficiency have focused primarily on attention/vigilance and working 
memory.
Attention/vigilance—Patients with schizophrenia have deficits in attentional processing. 
Attention is a multidimensional construct that can be divided into selective attention, or 
selecting the target stimulus, sustained attention or vigilance, focusing on the stimulus for a 
prolonged time, and attentional control in which attention is maintained despite distractions 
(Young et al. 2009b). In humans, attentional processes are measured with the continuous 
performance test. In rodents, the 5-choice serial reaction time task (5C-SRT) (Robbins 2002) 
and the 5-choice continuous performance task (5C-CPT) (Young et al. 2009a) are used to 
assess sustained attention. To date, no effect of DVD deficiency on attentional processing 
has been observed in rats (Turner et al. 2013) or C57BL/6J (B6J) mice (Harms et al. 2012b) 
in the 5C-SRT. In the 5C-CPT test, DVD deficiency resulted in increased premature 
responding thought to reflect increased impulsivity, and increased responding to non-target 
stimuli across all testing days, indicating a lack of response inhibition (Turner et al. 2013). 
Both of these behaviors could be prevented with acute treatment of the antipsychotic 
clozapine (Turner et al. 2013). The B6J mice exposed to DVD deficiency showed increased 
perseverative responses to the target stimuli in the 5C-CPT indicating a deficit in response 
inhibition (Harms et al. 2012b).
Latent inhibition (LI) is a learning phenomenon in which pre-exposure to an inconsequential 
stimulus diminishes future learning of new associations with that stimulus. The LI is 
disrupted in patients with schizophrenia (Lubow & Gewirtz 1995). In animal models, LI can 
be measured as the ability to ignore irrelevant stimuli in tests such as the shuttle box or fear 
conditioning. Deficits in LI in rats have been reported as a result of hippocampal lesions 
(Grecksch et al. 1999) and treatment with antipsychotics (Feldon & Weiner 1991). The 
DVD deficiency results in disrupted LI in the shuttle-box paradigm in rats (Becker et al. 
2005) but not in B6J mice in a fear conditioning paradigm (Harms et al. 2012b).
Prepulse inhibition (PPI) is the attenuation of a startle response when the startle stimulus is 
paired with a non-startling prepulse. Prepulse inhibition is a well-validated and frequently 
used test of sensorimotor gating, the neurological process of filtering out irrelevant stimuli. 
Patients with schizophrenia show deficits in PPI that respond to treatment with atypical 
antipsychotics (reviewed in Braff et al. 2001). Deficits in PPI have also been observed in 
patients with Huntington's disease and obsessive compulsive disorder (Braff et al. 2001). In 
rodents, manipulating neurotransmitter systems implicated in schizophrenia using DA 
agonists and N-methyl-D-aspartate (NMDA) antagonists results in PPI deficits (Geyer et al. 
2001). A recent paper using zebrafish ablated genomic screen homeobox 1 (Gsx1) 
expressing neurons using optogenetics and observed disrupted PPI. Similar PPI deficits were 
also observed in a Gsx1 knockout mouse (Bergeron et al. 2015). Gsx1 has been identified 
within a vulnerability locus in a genome-wide association study of neuropsychiatric 
disorders. These studies highlight the construct validity of PPI.
A study on rats reported a decrease in PPI in animals that were exposed to vitamin D 
deficiency throughout their entire life (perinatal + adulthood) but not those exposed only 
during the perinatal period (Burne et al. 2004b). Subsequent studies also found no PPI 
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deficits in response to DVD deficiency in rats (Burne et al. 2014; Kesby et al. 2006, 2012) 
or mice (Harms et al. 2008) exposed during the perinatal period alone. Additionally, PPI 
was not altered by the psychotomimetic MK-801 [NMDA receptor (NMDAR) antagonist] or 
the DA agonist, apomorphine, in DVD-deficient rats (Kesby et al. 2006, 2012). Prepulse 
inhibition is enhanced, however, after acute treatment with the psychomimetic cannabinoid 
agonist D9-tetrahydrocannabinol (THC) (Burne et al. 2014).
Schizophrenic patients also show deficits in habituation upon repeated exposure to a 
startling stimulus. These deficits are thought to reflect alterations in central inhibitory 
mechanisms (Braff et al. 1992; Geyer & Braff 1982). The DVD deficiency does not appear 
to have any effect on acoustic startle response in rats (Burne et al. 2004b, Kesby et al. 2006, 
2012) or mice (Harms et al. 2008). Similar to unexposed animals, acute treatment with 
MK-801 increases acoustic startle response in DVD-deficient rats (Kesby et al. 2012) while 
THC and apomorphine have no effect (Burne et al. 2014; Kesby et al. 2006).
Working memory, reasoning and problem solving—Patients with schizophrenia 
have impairments in working memory (Lee & Park 2005). However, modeling this form of 
memory in animals is complicated by subtle differences in how working memory is defined 
in humans vs. rodents. Behavioral tasks in rodents aimed at assessing working memory vary 
in the specific aspect being assessed (e.g. goal maintenance, memory capacity and 
interference control) (reviewed by Dudchenko et al. 2013). For the purposes of this review, 
we have grouped together a variety of behavioral tasks used to assess learning and memory 
in DVD-deficient rodents.
Rats exposed to DVD deficiency exhibited no baseline deficits in spatial working memory in 
the radial arm maze (Becker et al. 2005), learning acquisition or retention in a shuttle-box 
paradigm of active avoidance (Becker et al. 2005) or delay-dependent memory in the delay 
match to sample task (Burne et al. 2014). Moreover, there were no effects of DVD 
deficiency on decision-making processes in the rodent gambling task. The DVD-exposed 
animals showed significantly fewer omissions than control animals, suggesting an 
improvement in cognitive performance on this task (Peak et al. 2015). Rats exposed to DVD 
deficiency also showed decreased number of errors on the relearning session of the 
brightness discrimination task (Becker et al. 2005) indicating improved working memory. 
The DVD-deficient mice exhibited no deficits in fear conditioning (Harms et al. 2012b). 
One study, however, did find a significant impairment on working memory in DVD-
deficient B6J mice in the olfactory tubing maze, a hippocampal-dependent learning task 
(Fernandes de Abreu et al. 2010).
Taken together, the results of these studies assessing cognitive function suggest that 
exposure to DVD deficiency has very subtle effects that differ based on both species (rat vs. 
mouse), underlying genetics (outbred vs. inbred) and behavioral task. Furthermore, to our 
knowledge, none of the positive findings on cognitive deficiencies have been replicated. 
Therefore, future studies are required utilizing expanded behavioral measures and diverse 
genetic backgrounds.
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Some of the positive symptoms of schizophrenia such as hallucinations and delusions are 
impossible to assess in rodents. However, locomotion in a novel test environment is often 
used as a rodent model of the positive symptoms of psychomotor agitation and disorganized 
behavior. Rats with neonatal hippocampal lesions, a rodent model of schizophrenia, are 
hyperlocomotive in a novel environment (Black et al. 1998). Rats exposed to DVD 
deficiency also exhibit spontaneous hyperlocomotion in various behavioral assays including 
the open field (Burne et al. 2006; Eyles et al. 2006; Kesby et al. 2006), elevated plus maze 
(EPM) (Burne et al. 2004a) and holeboard test (Burne et al. 2004a, Kesby et al. 2006). 
However, these findings have not been consistent across all studies (Becker & Grecksch 
2006; Becker et al. 2005; Burne et al. 2014) indicating that the hyperlocomotion resulting 
from DVD deficiency might be sensitive to testing conditions and environment (i.e. test 
duration, lighting levels, etc.).
Hyperlocomotion was also reported in 129/SvJ (129), but not in B6J inbred, mice in the 
holeboard test and open field but not in the EPM (Harms et al. 2008) indicating that 
behavioral changes may be specific to both the type of test and genetic background in mice. 
Interestingly, spontaneous hyperlocomotion was not found in rats exposed to a vitamin D-
deficient diet after weaning and into adulthood indicating that gestation and the postpartum 
periods may be critical for the development of this behavior (Altemus et al. 1987; Burne et 
al. 2004a).
Spontaneous locomotion in the open field in rats exposed to DVD deficiency is blocked by 
acute exposure to restraint stress immediately prior to testing (Burne et al. 2006) – a finding 
that does not appear to be because of differences in Hypothalamic-Pituitary-Adrenal (HPA) 
axis reactivity (Eyles et al. 2006). However, exposure to stress also results in DA release in 
the brain (Anstrom & Woodward 2005) and DVD deficiency disrupts the development and 
functioning of the dopaminergic system (see Dopamine section below) providing a possible 
mechanism for the role of DVD deficiency and stress on spontaneous locomotion.
Negative symptoms
Negative symptoms reported in patients with schizophrenia include apathy, social deficits 
and lack of motivation. In rodents, exploratory behavior is used as an index of apathy and 
can be measured as a decrease in head dipping in the holeboard test. Rats exposed to a DVD 
deficiency show a decrease in head dipping, indicative of less exploratory activity (Becker 
& Grecksch 2006; Becker et al. 2005). This decrease in exploration is restored with 
subchronic treatment with haloperidol or the mGluR5 metabotropic gluta-mate receptor 
agonist, (R,S)-2-chloro-5-hydroxyphenylglycine CHPG; (Becker & Grecksch 2006). 
However, not all studies in rats have reported a difference in head-dipping behavior in the 
holeboard test (Burne et al. 2004a; Kesby et al. 2006) and a study of 129 and B6J mice 
exposed to DVD deficiency reported an increase in head dipping (Harms et al. 2008). 
However, interpretation of head-dipping behavior across studies may be confounded by the 
increased locomotor behavior in DVD-deficient animals that was observed in the latter three 
studies. Lack of habituation over multiple testing days in the holeboard test, as measured by 
head-dipping behavior, has also been reported in DVD-deficient rats (Becker & Grecksch 
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2006; Becker et al. 2005) and B6J, but not in 129 mice (Harms et al. 2008). Habituation in 
the holeboard test can be restored with subchronic treatment of haloperidol, CHPG and the 
atypical antipsychotic drug, risperidone (Becker & Grecksch 2006).
Lack of motivation to obtain a reward can be considered a measure of anhedonia, an aspect 
of depressive-like behavior. Rats exposed to DVD deficiency show decreased reward 
latency in the 5C-CPT task and an increase in the number of food rewards per session in the 
rodent gambling task suggesting increased motivation for reward (Peak et al. 2015; Turner 
et al. 2013). However, there was no alteration in reward latency in the 5C-SRT in rats 
exposed to DVD deficiency (Turner et al. 2013).
The DVD deficiency had no effect on immobility in another test of depressive-like behavior, 
the forced swim test in rats (Burne et al. 2004a) or mice (Harms et al. 2008). These data 
suggest that DVD exposure does not increase depressive-like behaviors, but may in fact 
increase motivation to obtain a reward. These findings also suggest that the underlying 
circuitry may differ between measures of depressive-like behavior (i.e. anhedonia vs. 
behavioral despair) and that exposure to DVD deficiency can have variable effects across 
different behaviors.
Asocial behavior is a core symptom of schizophrenia, affecting approximately one-third of 
patients. Social withdrawal and isolation emerge in the premorbid stage and persist 
throughout the illness (Wilson & Koenig 2014). Social behavior in rodents is assessed using 
the social interaction test (Nadler et al. 2004). Rats with neonatal lesions to the hippocampus 
show decreased social interaction in adolescence and adulthood, reflecting the emergence of 
social deficits in the premorbid stage (Sams-Dodd et al. 1997). The effect of DVD 
deficiency on social behavior in the social interaction test has been studied and no effect was 
observed in rats (Burne et al. 2004a) or mice (Harms et al. 2008). Lack of an effect of DVD 
deficiency on social interaction could indicate that the underlying pathology of social 
withdrawal is not related to pathways influenced by vitamin D. Alternatively, other social 
behaviors that have not been assessed (i.e. home cage behavior or nest building) might better 
capture the effects of DVD deficiency.
Mechanisms
Vitamin D has pleiotropic effects on cell differentiation and brain development in addition 
to its role as a neuroactive steroid (reviewed by Garcion et al. 2002). Animal models have 
been used to explore the mechanisms by which DVD deficiency can alter the brain, resulting 
in behavioral deficits in endophenotypes of schizophrenia. Table 2 summarizes studies 
aimed at identifying changes in brain circuitry, morphology and gene expression that might 
contribute to behavioral effects.
Glutamate
Glutamate neurotransmission, with emphasis on the NMDAR, is hypothesized to play a role 
in the pathophysiology of schizophrenia. This hypothesis was formulated based on the 
finding that administration of NMDAR antagonists such as MK-801, ketamine and 
phencyclidine resulted in psychosis in otherwise healthy individuals and mimicked 
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symptoms of schizophrenic patients (see Howes et al. 2015 for a review). In rodents, 
administration of NMDAR antagonist results in hyperlocomotion in the open field. The 
DVD deficiency has been shown to increase sensitivity to MK-801 in the open field in rats 
(Kesby et al. 2006, 2012; O'Loan et al. 2007), an effect that is blocked by haloperidol 
(Kesby et al. 2006). Increased locomotor sensitivity to MK-801 was not seen in rats whose 
mothers were exposed to a vitamin D-deficient diet prior to conception but not during 
gestation, indicating that gestation and the perinatal period constitute a critical exposure 
window to induce a persistent effect (O'Loan et al. 2007). Decreased MK-801 binding in the 
caudate putamen was also observed in DVD-exposed rats (Kesby et al. 2012), suggesting a 
reduction in NMDAR function. Behavioral effects in response to MK-801 were not 
observed in either 129 or B6J mice (Harms et al. 2012a). These data suggest that 
glutamatergic transmission through NMDARs is disrupted in rats exposed to DVD 
deficiency, a finding that compares to what is seen in schizophrenic patients.
Future studies are needed to assess gamma-aminobutyric acid (GABA) neurotransmission in 
relation to exposure to DVD deficiency. A reduction in GABA-synthesizing enzymes 
GAD65 and GAD67 in prefrontal cortex and hippocampus has been reported in patients 
with schizophrenia (reviewed in Lewis et al. 2012). A recent study that employed 
pharmacogenetic techniques (designer receptors exclusively activated by designer drugs) to 
specifically inhibit GABA interneurons expressing parvalbumin or GAD65 in the ventral 
hippocampus of mice observed hyperlocomotion and deficits in spatial working memory and 
PPI (Nguyen et al. 2014). Dysregulation of GABA transmission should be investigated as a 
possible mechanism linking exposure to DVD deficiency and hyperlocomotion. There is 
evidence that GABA transmission is dysregulated in DVD-deficient animals based on two 
studies that looked at gene expression in whole brain from adult rats exposed to DVD 
deficiency. These studies identified a decrease in expression of GABA-Aα4 (Feron et al. 
2005) and GABA B receptor 1 (Eyles et al. 2007). However, other studies have reported no 
difference in GABA transmission (Almeras et al. 2007; McGrath et al. 2008), although the 
discrepancies between studies could be due to differences in brain regions analyzed. Clearly, 
future studies investigating the GABA system in DVD-deficient animals are warranted.
Dopamine
Schizophrenic patients show a clear dysregulation of the DA system that is thought to 
contribute to the emergence of positive symptoms. The presence of the VDR in 
dopaminergic neurons in the substantia nigra and its expression at appropriate time points 
during development (Cui et al. 2013) suggests that vitamin D can have an effect on the 
developing DA system in the brain.
Exposure to DVD deficiency in rodents results in dysregulation of the developing 
dopaminergic system in the brain. In the rat fetal mesencephalon, DVD deficiency leads to 
reduction of two important factors for specification of dopaminergic neurons, Nurr1 and 
p57Kip2 (Cui et al. 2010). In BALB/c mice, exposure to DVD deficiency increases gene 
expression of an important factor in neuronal survival and neuroprotection of dopaminergic 
cells (transforming growth factor β1, Tgf-β1) and a decrease in both gene and protein 
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expression of the DA synthesizing enzyme, tyrosine hydroxylase (Th), in the substantia 
nigra at ED17.5 (Hawes et al. 2015).
While it is clear the DVD deficiency disrupts the developing dopaminergic system, this 
effect does not appear to be as apparent in the expression of DA signaling proteins in the 
adult rat brain (Almeras et al. 2007; McGrath et al. 2008). However, the functioning of these 
proteins could be impaired without altering protein levels. A study by Kesby et al. (2009) 
found that there was a decrease in conversion of the DA metabolite 3,4-
dihydroxyphenylacetic acid to homovanillic acid and a decrease in expression of the needed 
enzyme in this reaction, catechol-O-methyltransferase in the DVD-deficient neonatal rat 
brain (Kesby et al. 2009). Adult female rats exposed to DVD deficiency had increased DA 
transport density in the caudate putamen and increased DA affinity in the nucleus 
accumbens indicating that the functioning of the DA proteins was enhanced (Kesby et al. 
2010).
Increased psychostimulant-induced DA release in the striatum has been observed in patients 
with schizophrenia (Breier et al. 1997). In rodent models, psychostimulants such as 
amphetamine, that induce the release of DA and increase locomotor behavior, are 
administered to assess functioning of the dopaminergic system. The DVD deficiency in 
female but not in male rats results in increased locomotor response to amphetamine in 
adulthood (Kesby et al. 2010). This finding was not observed in juvenile rats, mimicking the 
adult onset that is typical of schizophrenia (Kesby et al. 2010). Interestingly, increased 
sensitivity to amphetamine was not seen in DVD-exposed B6J or 129 inbred mice indicating 
that species-specific and possibly genetic background differences exist (Harms et al. 2012a). 
Collectively, these studies show that vitamin D deficiency during development has a 
significant effect on the development and functioning of the dopaminergic system and that 
there is a behavioral manifestation of DA dysregulation in adulthood in rats.
Maternal care
The quality of maternal care has been shown to have a consistent and appreciable effect on 
behavior in adult offspring (Francis et al. 1999; Szyf 2013) leading one to question whether 
maternal behavior differs among mothers exposed to vitamin D deficiency. Interestingly, a 
study by Burne et al. (2011) showed that exposure to DVD deficiency increases maternal 
behaviors in the rat. The DVD-deficient mothers perform more sniffing, carrying and 
retrieval of pups in a pup retrieval test (Burne et al. 2011). Pups exposed to higher levels of 
maternal care have previously been shown to have a lower corticosterone response to a 
stressor and less anxiety-like behavior in adulthood than pups of dams who exhibit low 
amounts of maternal behaviors (see review by Francis & Meaney 1999). Furthermore, it is 
thought that maternal behavior is stimulated, in part, in response to pup ultrasonic 
vocalizations, which are mediated by the DA system (Dastur et al. 1999). Since the 
dopaminergic system is altered by DVD deficiency (Cui et al. 2007, 2010; Kesby et al. 
2009, 2010), Burne et al. (2011) examined the effect of DVD deficiency on calling rate of 
isolation-induced ultrasonic vocalizations but observed no differences.
A recent study examined the effect of exposure to DVD deficiency in BALB/c mice and 
reported that mothers on the vitamin D-deficient diet had significantly increased 
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corticosterone levels during pregnancy, indicating higher stress levels (Tesic et al. 2015). 
Tesic et al. also reported that the placenta of DVD-exposed mothers showed deficiencies in 
11β-hydroxysteroid dehydrogenase type 11, which inactivates glucocorticoids and protects 
the fetus from overexposure, and an increase in a highly sensitive glucocorticoid factor 
(Tesic et al. 2015). These findings would suggest that developing pups of vitamin D-
deficient BALB/c mothers are being exposed to high levels of stress hormones in utero. The 
findings of this study are in contrast to a previous study in rats that found no difference in 
corticosterone levels at baseline or after a restraint stress in pregnant dams exposed to a 
DVD-deficient diet or their male offspring in adulthood (Eyles et al. 2006). These 
conflicting results highlight the recurring finding of species differences in response to DVD 
deficiency and emphasize the need for future studies directed at identifying potential 
mechanisms.
Structural brain abnormalities
Structural brain abnormalities in patients with schizophrenia include decreased overall brain, 
temporal lobe and amygdala/hippocampal volume and increased lateral ventricles (reviewed 
by Lawrie & Abukmeil 1998). Rats exposed to DVD deficiency were also found to have 
enlarged lateral ventricles and a thinner cortex at birth (Eyles et al. 2003; Feron et al. 2005). 
However, the opposite phenotype was seen in mice. Mice exposed to DVD deficiency have 
smaller lateral ventricles in utero (Hawes et al. 2015) and in adulthood (Fernandes de Abreu 
et al. 2010; Harms et al. 2012a). The DVD deficiency also resulted in a larger striatum and 
smaller hippocampus in adult B6J males and a smaller hippocampus in females at birth 
(Fernandes de Abreu et al. 2010; Harms et al. 2012a).
Vitamin D has anti-proliferative, pro-apoptotic and differentiation properties in various cell 
types (Berridge 2015). Embryonic rat hippocampal neurons treated with vitamin D had a 
decreased percentage of cells in mitosis and increased neurite outgrowth (Brown et al. 2003) 
and mouse hippocampal neurons treated with vitamin D showed a decrease in cell 
proliferation and an increase in differentiation (Marini et al. 2010). Conversely, rats exposed 
to DVD deficiency exhibited an increased number of mitotic cells from gestation into the 
early postnatal period (Eyles et al. 2003; Ko et al. 2004), upregulation of pro-mitotic genes 
involved in cell cycle progression and a decrease in apoptosis and pro-apoptotic gene 
expression (Ko et al. 2004). Primary hippocampal cultures from rats exposed to DVD 
showed an increased number of neurospheres in the subventricular zone indicating increased 
activity of neural progenitor cells (Cui et al. 2007). Taken together, these results suggest that 
vitamin D plays a role in promoting healthy cellular development of the brain and a 
deficiency of this key regulator during brain development in utero can lead to brain 
abnormalities similar to those seen in schizophrenic patients. More research is needed to 
examine the differences in brain abnormalities in rats vs. mice and determine if this could 
explain some of the behavioral differences between the two species. If so, examination of 
these differences would provide insight into resilience vs. susceptibility to develop 
schizophrenia in those exposed to vitamin D deficiency during the perinatal period.
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Neurotrophins such as nerve growth factor (NGF) and brain-derived neurotrophic factor 
(BDNF) have been implicated in the pathophysiology of schizophrenia. Nerve growth factor 
and BDNF are involved in promotion of neuronal growth and differentiation in the 
developing nervous system and synaptic plasticity throughout life. Peripheral BDNF and 
NGF levels are reduced in patients with schizophrenia both before and during treatment with 
antipsychotics (reviewed by Green et al. 2011; Martinotti et al. 2012; Weickert et al. 2003). 
However, there is some debate in the literature with regard to BDNF levels since a few 
studies have reported increased BDNF levels (Autry & Monteggia 2012; Martinotti et al. 
2012). Differences between studies are thought to reflect treatment with antipsychotics, 
brain region and sample type (e.g. serum, whole blood and brain tissue). Regardless, there is 
general agreement in the literature that NGF and BDNF are dysregulated in schizophrenic 
patients and animal models of schizophrenia (Pillai 2008). However, a gap still exists 
linking neurotrophic dysregulation and manifestation of symptoms.
Vitamin D has been shown to result in NGF production in vitro in cultured embryonic rat 
hippocampal neurons (Brown et al. 2003). Conversely, as anticipated, exposure to DVD 
deficiency results in a decrease in NGF as well as glial cell line-derived neurotrophic factor 
and low affinity neurotrophin receptor p75NTR at birth (Eyles et al. 2003; Feron et al. 2005). 
Decreases in NGF also persist into adulthood (Eyles et al. 2003). Exposure to DVD 
deficiency also results in decreased Bdnf gene expression in BALB/c mice at ED14.5 but 
increased expression at ED17.5 compared with control animals (Hawes et al. 2015). A 
decrease in neurotrophic factors in DVD-deficient rodent models mimics what is reported in 
patients with schizophrenia indicating that vitamin D might play a mechanistic role in 
neurotrophic dysregulation. It is possible that the decrease in neurotrophic factors observed 
in both schizophrenics and DVD-deficient rodents might contribute to cognitive behaviors 
such as learning and memory where synaptic plasticity plays a major role.
Dysregulation of gene and protein expression in the brain
The ability of exposures in development to induce behavioral changes in adulthood are 
thought to be because of altered gene expression, possibly through epigenetic mechanisms 
that can persist over time (Isles 2015). Identifying genes that are altered in response to a 
specific manipulation (i.e. vitamin D deficiency) is challenging because of the complexity of 
the genome. However, detecting gene expression changes in response to vitamin D 
deficiency in development can provide insight into the mechanisms that result in behavioral 
changes in adulthood and ultimately provide targets for treatment. Whole-brain tissue from 
adult rats exposed to DVD deficiency showed dysregulated expression of 74 genes involved 
in oxidative phosphorylation, redox balance, cytoskeleton maintenance, calcium 
homeostasis, synaptic plasticity, neurotransmission, chaperoning and posttranslational 
modifications, with the majority of the genes being downregulated (Eyles et al. 2007). In 
concordance with this finding, the same study also reported dysregulation of protein 
expression in the same cellular processes for 17 and 23 proteins in the frontal cortex and 
hippocampus, respectively, and 4 proteins in both regions (Hs7C, Tbb1, EnoG and ATPb) 
(Almeras et al. 2007). Again, the majority of these proteins were found to be downregulated 
in adult rats exposed to DVD deficiency and were localized to mitochondria, cytoskeleton 
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and synapses (Almeras et al. 2007). A similar study examined protein expression in the 
nucleus accumbens and found significant downregulation of 22 proteins and upregulation of 
13 proteins in rats exposed to DVD deficiency (McGrath et al. 2008). Dysregulated proteins 
in the nucleus accumbens included calcium binding, dynamin-like and mitochondrial 
proteins (McGrath et al. 2008). Of note, there was no overlap in dysregulated proteins 
identified in the nucleus accumbens, frontal cortex and hippocampus (Almeras et al. 2007; 
McGrath et al. 2008). In another study analyzing specific genes of interest via RT-PCR, 
exposure to a vitamin D-deficient diet in the DVD model or DVD + postnatal period 
resulted in decreased expression of genes involved in neuronal structure including Gabra4, 
Map2 and Nefl in whole brain from adult rats (Feron et al. 2005).
The biological processes identified in gene and protein expression studies from 
schizophrenics and rodents exposed to DVD deficiency show considerable overlap. Gene 
expression microarray analysis of prefrontal cortex tissue from schizophrenics identified 
downregulation of genes involved in presynaptic function including N-ethylmaleimide 
sensitive factor (Nsf) and synapsin II (Syn2) (Mirnics et al. 2000). N-ethylmaleimide 
sensitive factor was also downregulated in whole brain (Eyles et al. 2007) and the SYN2 
protein was upregulated in the frontal cortex of rats exposed to DVD deficiency (Almeras et 
al. 2007). Another study compared postmortem brain tissue of schizophrenic patients and 
healthy controls using proteomic and microarray analysis and found that 90% of 
dysregulated genes were involved in mitochondrial function, specifically energy metabolism 
and oxidative stress (Prabakaran et al. 2004). Specific proteins (capitalized) and genes 
(lowercase) that are dysregulated in both brain tissue from schizophrenic patients and rats 
exposed to DVD deficiency include those involved in neurotransmission (MAPK2, ENOG, 
143G, VIS1, GAP43, SYN2, Nsf, Dlgh1, Glul, Syt1, Cplx2 and Gabbr1), cytoskeleton 
maintenance (DREB, GFAP, Map2, Kic1, Gfap and Ckb), mitochondrial functioning 
(MDHC, COX6a1, ATPB, Atpb and Sod2), posttranslational modifications (PSA2, HS7C, 
UCHL1, Psa2 and Uchl1) and the calcium-binding protein, Ppp3r1 (Almeras et al. 2007; 
Eyles et al. 2007; McGrath et al. 2008). Apolipoprotein E (ApoE) is downregulated in 
hippocampal tissue from adult rats exposed to DVD deficiency and allelic differences in 
ApoE have also been observed in postmortem tissue from schizophrenics (Harrington et al. 
1995).
The studies discussed above provide a platform on which to begin to unravel the pathways 
by which DVD deficiency is altering the genome. More research is needed to understand 
how vitamin D is altering expression of these genes (i.e. epigenetic changes) and if the 
changes induced by DVD deficiency interact with genetic background.
Conclusions and future directions
The studies discussed above highlight subtle and specific alterations in behavior and neural 
development that result from exposure to a diet deficient in vitamin D during critical periods 
of development. These studies have also begun to elucidate the complex underlying 
mechanisms for how exposure to a diet deficient in vitamin D in gestation can lead to 
persistent changes in behavior in adulthood. These findings include disruption of normal 
brain development, dysregulation of specific genes and protein systems and alterations of 
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the dopaminergic system and key neurotrophic factors. However, it is important to note that 
most of these studies were conducted in Sprague-Dawley rats. There are very few studies of 
DVD deficiency that have been conducted in mice. Mice are not necessarily a better model 
system than rats, but do offer some advantages in terms of tools available for genomic 
analysis and mechanistic studies. Importantly, there are both congruent and disparate results 
between studies utilizing rats vs. mice (Table 3). It should be noted that the rat studies were 
conducted on a genetically heterogeneous, outbred background while the mouse studies 
were performed in genetically homogeneous inbred strains. The observed differences 
between rats and mice could indicate gene by environment interactions where the effect of 
exposure to vitamin D deficiency in development on a specific phenotype depends on 
genetic background. Therefore, one future direction is to assess the effect of DVD 
deficiency on a genetically diverse set of rodents such as the Collaborative Cross (Churchill 
et al. 2004) that has been optimized for systems genetics studies or outbred mice (Churchill 
et al. 2012; Schmidt 2015) to more completely assess gene by environment interactions and 
potential causative mechanisms.
The behavioral effects of DVD exposure vary based on the behavioral assessment used (i.e. 
hyperlocomotion in various assays and diverse learning tasks). Furthermore, the behavioral 
effects observed in rats were not always replicable even within the same laboratory, 
indicating that the behavioral effects of DVD deficiency may be unstable or sensitive to 
subtle differences in the environment. This is particularly important based on our 
observation that the majority of the literature on DVD deficiency has come from the same 
research group at The University of Queensland in Australia. Although this group has 
carried out a thorough job characterizing numerous behavioral phenotypes and the 
underlying mechanisms responsible for persistent changes in behavior, there is a need for 
additional studies by other groups to determine if these subtle behavioral phenotypes can be 
reproduced.
Collectively, we can conclude that exposure to a diet deficient in vitamin D during 
development can lead to subtle behavioral changes in adulthood and that these changes are 
dependent on the timing of the exposure, the model system (rats vs. mice) and genetic 
background.
These studies highlight the potential importance of monitoring vitamin D levels in pregnant 
women. The World Health Organization released a report in 2012 and concluded that 
vitamin D supplementation was not recommended for pregnant women as part of the 
standard of care (World Health Organization, 2012). However, the effects of in utero 
exposure to low vitamin D on mental health in adulthood were not considered. More work 
needs to be carried out in this area if we are to truly understand the role of vitamin D 
deficiency in schizophrenia and gain a better understanding of the neurobiological systems 
that are affected and increase risk for this devastating disease.
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Table 1
Commonly used animal models to measure schizophrenia endophenotypes
Human correlate Animal model References
Positive Psychomotor agitation Locomotor activity and response to novelty Farrow et al. (2006); Young et 
al. (2007)
Disorganized behavior Patterns of locomotor activity Young et al. (2007)
Negative Anhedonia Saccharine or sucrose consumption, intracranial 
self-stimulation
Amitai et al. (2009); Berlin et 
al. (1998); Le Pen et al. 
(2002)
Avolition (lack of motivation) Progressive ratio, conditioning paradigms Wiley and Compton (2004)
Social withdrawal Social interaction Nadler et al. (2004)
Resident intruder Ellenbroek and Cools (2002)
Nest building Belforte et al. (2010)
Home cage social behavior Torres et al. (2005)
Cognitive Working memory T-maze, holeboard, radial arm maze File and Wardill (1975); Levin 
et al. (1996)
Visual learning and memory Morris water maze, novel object recognition, Barnes 
maze
Barnes (1979); Chen et al. 
(2000); Dere et al. (2007); 
Ennaceur and Delacour 
(1988); Morris (1981); Paylor 
et al. (2001)
Reasoning/problem solving Attentional set shifting; cross-maze-set-shifting 
task; serial reversal acquisition paradigm, rodent 
gambling task
Birrell and Brown (2000); 
Colacicco et al. (2002); 
Ragozzino et al. (1999); 
Widholm et al. (2001); Zeeb 
et al. (2009)
Attention/vigilance 5C-SRT 5C-CPT Robbins (2002); Young et al. 
(2009a)
Processing speed 5C-SRT 5C-CPT, olfactory discrimination Slotnick (2001); Uchida and 
Mainen (2003)
Social cognition Social interaction or recognition Ferguson et al. (2002); Nadler 
et al. (2004)
Endophenotypes Increased sensitivity to 
psychostimulants (e.g. 
amphetamine and cocaine)
Measurement of locomotor activation following 
administration of psychostimulants
van den Buuse et al. (2005)
Impaired sensorimotor gating 
(pre-attention)
PPI of startle response Geyer et al. (2001)
Impaired auditory evoked 
potentials
Auditory-evoked potential measurement Connolly et al. (2003)
Impaired LI Shuttle-box, fear-conditioning Feldon and Weiner (1991); 
Mongeau et al. (2007)
Impaired mismatch negativity Mismatch negativity in anesthetized rodents Umbricht et al. (2005)
Alterations in neurochemistry Neurochemistry and microdialysis measurements Di Matteo et al. (2008); Lodge 
and Grace (2008)
Sleep disturbances Electroencephalogram measurements, sleep-wake 
cycles
Cohrs (2008); Dzirasa et al. 
(2006);
Mood (anxiety) Open field, EPM, light/dark, holeboard, marble 
burying; stress-induced hyperthermia
Borsini et al. (1989); Crawley 
(1981); Gardner and Piper 
(1982); Njung'e and Handley 
(1991); Prut and Belzung 
(2003); Rodgers and Johnson 
(1995);
Mood (depression) Forced swim test, tail suspension test, learned 
helplessness
Porsolt et al. (1977); Seligman 
and Beagley (1975); Steru et 
al. (1985)
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Human correlate Animal model References
Self-care Grooming, body weight, coat condition, general 
health, barbering, etc.
Audet et al. (2006)
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Table 2
Literature summary of the effects of exposure to DVD deficiency in rodents
Species Strain Sex Deficiency Exposure timing Age at testing Outcome 
(increase (↑) or 
decrease (↓) 
relative to control 
diet)
References





DVD PND0 ↑ Lateral ventricles
↓ Cortical thickness
↑ Mitotic cells in 
DG, Hypo, BG
↓ NGF and GDNF
↓ p75NTR mRNA 
and protein 
expression












PND21) vs. Life 
(DVD-PND70)
PND70 ↑ Locomotion in 
holeboard test and 













PND21) vs. Life 
(DVD-PND70) 
vs. AVD (PND 
35–70)
PND35 and PND70 ↓ PPI in Life group 
only at PND 70
Burne et 
al. (2004b)





DVD ED19, ED21, PND0, P7 ↓ Apoptotic cells in 
BG, Hypo, 
cingulate, DG at 
E21 and E23
↑ Mitotic cells in 
dentate at E19 and 
E21 and BG at P7
↓ Pro-apoptotic 
gene expression




Ko et al. 
(2004)








DVD PND56 Impaired LI (in an 
active avoidance 
task)
↓ Habituation over 
time in holeboard
↓ Exploratory 
behavior of novel 
olfactory stimuli 
(Day 5 of 
holeboard)
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Species Strain Sex Deficiency Exposure timing Age at testing Outcome 
(increase (↑) or 
decrease (↓) 


















↓ NGF in both 
groups
↓ GABA-Aα4 and 
MAP-2 gene 
expression in both 
groups
↓ NF-L gene 
expression in DVD 
group
Feron et al. 
(2005)






















DVD PND70 ↑ Locomotion in 
open field
Eyles et al. 
(2006)
Rat Sprague-Dawley M Vitamin D (0 




























DVD PND56 ↑ Locomotion in 
the open field 
(prevented with 5-
min acute restraint 









DVD PND70 Dysreguiated 
expression of 17 
proteins in the FC
Dysregulated 
expression of 23 




Hs7C, Tbb1, EnoG 
and ATPb proteins 









DVD PND0 ↑ Number of 
neurosphere in 
SVZ cultures
Cui et al. 
(2007)
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Species Strain Sex Deficiency Exposure timing Age at testing Outcome 
(increase (↑) or 
decrease (↓) 
relative to control 
diet)
References





DVD PND70 Dysregulated 
expression of 74 
genes
Eyles et al. 
(2007)





Early DVD (4 
weeks before 
mating) vs. late 
DVD (E0–E21) 
vs. full DVD
PND70 ↑ MK-801-induced 









DVD PND70 ↓ Protein 
expression of 22 
proteins in NAc
↑ Protein 









DVD P0 ↑ DOPAC/HVA in 
forebrain













DVD ED12 and ED15 ↓ Nurr1 expression 





Cui et al. 
(2010)





DVD PND35 and PND70 ↑ Amphetamine-
induced 
locomotion
↑ DAT density in 
CPu
↑ DAT affinity in 
























































DVD PND180 ↑ THC-induced PPI Burne et 
al. (2014)
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Species Strain Sex Deficiency Exposure timing Age at testing Outcome 
(increase (↑) or 
decrease (↓) 





Rat Sprague-Dawley F and M Vitamin D 
(0, 1.5, 3.3, 









PND35-40 and PND100-105 ↑ Grooming 
behavior in EPM at 
PND35-40 in 0 
group











DVD PND210-290 ↓ Training sessions 
required to meet 
criteria in the 
rodent gambling 
task




Peak et al. 
(2015)
Mice 129/SvJ (129) 
and C57BL/6J F and M





DVD PND70 ↑ Head dipping in 
both strains
↓ Habituation to 
holeboard test in 
B6J
↑ Locomotion in 








DVD PND210 and PND420 ↓ Lateral ventricles 
PND210









Mice C57BL/6J (B6J) 
and 129/X1SvJ





DVD PND0 (MRI) and PND70 
(MRI and behavior)
↓ Hipp in B6J 
females at PND0
↓ Lateral ventricles 
in B6J males at 
PND70











DVD PND140 ↑ Repetitive 
responses (nose 




Mice BALB/c F and M Vitamin D (0 
IU/kg with 












↓ Lateral ventricle 
volume at ED17.5
↓ Bdnf gene 
expression at 
ED14.5
↑ Bdnf gene 
expression at 
ED175
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Species Strain Sex Deficiency Exposure timing Age at testing Outcome 
(increase (↑) or 
decrease (↓) 
relative to control 
diet)
References
↓ Foxp2 gene 
expression at 
ED14.5
↑ Foxp2 gene 
expression at 
ED17.5
↓ Th gene 
expression at 
ED175 in F
↓ Foxp2 expression 
in cortex at ED17.5 
in F
↓ TH expression in 
SN at ED175 in F
Mice BALB/c F and M Vitamin D (0 
IU/kg with 
















Tesic et al. 
(2015)
Acb, accumbens; AVD, adult vitamin D deficiency; BG, basal ganglia; Ca, calcium; Cingulate, cingulate gyrus of the cortex; COMT catechol-O-
methyl transferase; CORT, corticosterone; CPu, caudate putamen; DG, dentate gyrus of the hippocampus; DOPAC, 3,4-dihydroxyphenylacetic 
acid; ED, embryonic day; F, female; FC, frontal cortex; Foxp2, forkhead box protein P2; GDNF, glial cell line-derived neurotrophic factor; Hipp, 
hippocampus; HVA, homovanillic acid; Hypo, hypothalamus; M, male; NAc, nucleus accumbens; PND, postnatal day; SN, substantia nigra; SVZ, 
subventricular zone.
*
Female and male offspring were tested; however, data were pooled for analysis because of no significant effect of vitamin D diet × sex effects.
†
Tissues from female and males were taken and data pooled without analyzing separately.
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Table 3
Comparison of findings of DVD deficiency in rats vs. mice. ND = No Difference Observed
Behavior Sprague-Dawley rat Inbred mice References
PPI ND ND Burne et al. (2014); Harms et al. (2008); Kesby et 
al. (2006, 2012)
Attentional processing: 5C-SRT ND ND Harms et al. (2012b); Turner et al. (2013)
Sustained attentional processing: 
response inhibition in 5C-CPT
↓ ↓ Harms et al. (2012b); Turner et al. (2013)
LI Disrupted ND Becker et al. (2005); Harms et al. (2012b)
Head dipping: holeboard test ↓ ↑ Becker and Grecksch (2006); Becker et al. (2005); 
Harms et al. (2008)
Habituation: holeboard test ↓ ↓ in B6J ND in 129 Becker and Grecksch (2006); Becker et al. (2005); 
Harms et al. (2008)
Social interaction ND ND Burne et al. (2004a); Harms et al. (2008)
Anxiety-like behavior: EPM ND ND Burne et al. (2004a); Harms et al. (2008)
Spontaneous hyperlocomotion ↑ ↑ in 129 ND in B6J Burne et al. (2004a, 2006); Eyles et al. (2006); 
Harms et al. (2008); Kesby et al. (2006)
MK-801-induced locomotion ↑ ND Harms et al. (2012a); Kesby et al. (2006, 2012); 
O'Loan et al. (2007)
Amphetamine-induced locomotion ↑ ND Harms et al. (2012a); Kesby et al. (2010)
Lateral ventricle size ↑ ↓ Eyles et al. (2003); Fernandes de Abreu et al. 
(2010); Feron et al. (2005); Harms et al. (2012a); 
Hawes et al. (2015)
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